Attenuation of Psoriasis Symptoms Following Treatment with C-phycocyanin from Spirulina Maxima in a Mouse Model

Jin Young Jang,Byung Man Lee,Sang Yoon Jun,Yun Jung Yang,Hwa Sung Shin
DOI: https://doi.org/10.1007/s12257-022-0022-z
IF: 3.386
2022-06-30
Biotechnology and Bioprocess Engineering
Abstract:Psoriasis is a chronic autoimmune disease caused by an abnormal proliferation of keratinocytes in the epidermis. The efficacy of C-Phycocyanin, a photosynthetic pigment isolated from Spirulina Maxima , was assessed via histological examinations, and anti-inflammatory properties were investigated in mouse models of imiquimod-induced psoriasis (BALB/C-nu and BALB/C). C-phycocyanin lowered epidermal thickening, as well as immune cell clustering in the dermis. Furthermore, C-phycocyanin modulated the levels of inflammatory cytokines (tumor necrosis factor-α, interleukin [IL]-6, cyclooxygenase-2, IL-1b) in the BALB/C-nu mouse model and psoriasis-related cytokines (IL-17a, interferon-gamma, calcitonin gene-related peptide) in BALB/c mice. We show that C-phycocyanin could be developed as a natural pharmaceutical against psoriasis.
biotechnology & applied microbiology
What problem does this paper attempt to address?